Breaking News Instant updates and real-time market news.

ARQL

ArQule

$3.62

0.22 (6.47%)

16:40
05/17/18
05/17
16:40
05/17/18
16:40

ArQule files to sell 10.63M shares of common stock for holders

ARQL ArQule
$3.62

0.22 (6.47%)

02/22/18
ROTH
02/22/18
INITIATION
Target $5
ROTH
Buy
ArQule initiated with a Buy at Roth Capital
Roth Capital analyst Jotin Marango started ArQule with a Buy rating and $5 price target, contending that near and medium term value inflections for its AKT and BTK inhibitors could be "transformational for the company and its investors." He advises investors to keep an eye on initial data from the first cohort of the Phase 1 study of ARQ 531 in refractory B-cell tumors, likely at AACR in April and/or ASCO in June, as well as the publication of full data from the NIH Phase 1 study of Miransertib in Proteus.
03/26/18
RILY
03/26/18
NO CHANGE
Target $4
RILY
Buy
ArQule price target raised to $4 from $3.50 at B. Riley FBR
B. Riley FBR analyst George Zavoico raised his price target for ArQule to $4 saying the company has three drug poised to advance into later stage clinical trials. The analyst keeps a Buy rating on the shares.
04/05/18
LEER
04/05/18
UPGRADE
Target $5
LEER
Outperform
ArQule upgraded to Outperform from Market Perform at Leerink
Leerink analyst Jonathan Chang upgraded ArQule to Outperform from Market Perform and raised his price target on the shares to $5 from $1.50 after assuming coverage of the stock. The analyst has a positive view on the stock ahead of multiple clinical catalysts expected in 2018 and view the risk/reward profile as attractive.
04/17/18
ROTH
04/17/18
NO CHANGE
Target $6
ROTH
Buy
ArQule price target raised to $6 after AACR meeting at Roth Capital
Roth Capital analyst Jotin Marango noted that ArQule presented clinical data on its BTK inhibitor ARQ 531 and its AKT inhibitors Miransertib and ARQ 751 at the AACR meeting this weekend and subsequently reported the outlicensing of its FGFR inhibitor derazantinib. He believes that over the last few days the company has been able monetize its "riskier and costlier program" while presenting data that build material value into its rising programs, Marango tells investors. He raised his price target on ArQule shares to $6 from $5 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

09:32
09/19/18
09/19
09:32
09/19/18
09:32
Conference/Events
Credit Suisse financial services analysts hold analyst/industry conference call »

Analysts discuss their…

CXW

CoreCivic

$25.49

-0.025 (-0.10%)

09:30
09/19/18
09/19
09:30
09/19/18
09:30
Hot Stocks
CoreCivic enters into management contract with Vermont Department of Corrections »

CoreCivic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APOG

Apogee Enterprises

$42.48

-5.59 (-11.63%)

09:30
09/19/18
09/19
09:30
09/19/18
09:30
Recommendations
Apogee Enterprises analyst commentary  »

Apogee Enterprises price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$218.24

0.38 (0.17%)

09:28
09/19/18
09/19
09:28
09/19/18
09:28
Periodicals
Apple expects iPhone XR shipments to ramp up in October, DigiTimes reports »

Shipments of Apple's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$124.70

1.99 (1.62%)

09:27
09/19/18
09/19
09:27
09/19/18
09:27
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy added…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:27
09/19/18
09/19
09:27
09/19/18
09:27
Hot Stocks
Breaking Hot Stocks news story  »

SilverCrest Metals Inc…

WMGI

Wright Medical

$27.41

0.46 (1.71%)

09:27
09/19/18
09/19
09:27
09/19/18
09:27
Recommendations
Wright Medical analyst commentary  »

Doctor survey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

UAL

United Continental

$90.13

-0.02 (-0.02%)

09:25
09/19/18
09/19
09:25
09/19/18
09:25
Conference/Events
United Continental management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

INSM

Insmed

$19.51

0.55 (2.90%)

09:22
09/19/18
09/19
09:22
09/19/18
09:22
Recommendations
Insmed analyst commentary  »

Insmed price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 01

    Oct

NTCT

NetScout

$25.60

0.5 (1.99%)

09:22
09/19/18
09/19
09:22
09/19/18
09:22
Conference/Events
NetScout management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 06

    Nov

09:20
09/19/18
09/19
09:20
09/19/18
09:20
General news
The U.S. current account gap narrowed »

The U.S. current account…

HIL

Hill International

$0.00

(0.00%)

09:19
09/19/18
09/19
09:19
09/19/18
09:19
Hot Stocks
Hill to provide project, construction management for Brazilian projects »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MUSA

Murphy USA

$82.81

0.78 (0.95%)

09:18
09/19/18
09/19
09:18
09/19/18
09:18
Conference/Events
Murphy USA management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
09/19/18
09/19
09:18
09/19/18
09:18
Options
Overnight activity included 254 trades in SPX and 10 trades in VIX »

254 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXLS

ExlService

$65.57

0.56 (0.86%)

09:14
09/19/18
09/19
09:14
09/19/18
09:14
Conference/Events
ExlService management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

RILY

B. Riley Financial

$22.05

0.4 (1.85%)

09:13
09/19/18
09/19
09:13
09/19/18
09:13
Hot Stocks
B. Riley Financial subsidiary serves as placement agent in $96.9M capital raise »

B. Riley FBR, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VET

Vermilion Energy

$32.10

0.73 (2.33%)

09:13
09/19/18
09/19
09:13
09/19/18
09:13
Initiation
Vermilion Energy initiated  »

Vermilion Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HURN

Huron

$49.95

1.05 (2.15%)

09:12
09/19/18
09/19
09:12
09/19/18
09:12
Recommendations
Huron analyst commentary  »

Huron has 'hidden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 22

    Oct

NFLX

Netflix

$367.85

17.61 (5.03%)

, SKYAY

Sky

$0.00

(0.00%)

09:12
09/19/18
09/19
09:12
09/19/18
09:12
Hot Stocks
Netflix to be added to new Sky service bundle in November »

Sky (SKYAY) announced…

NFLX

Netflix

$367.85

17.61 (5.03%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

DPZ

Domino's Pizza

$281.76

7.4 (2.70%)

09:11
09/19/18
09/19
09:11
09/19/18
09:11
Conference/Events
Domino's Pizza management to meet with Oppenheimer »

Meeting to be held in Ann…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 26

    Sep

  • 05

    Oct

  • 06

    Nov

TGEN

Tecogen

$3.08

-0.09 (-2.84%)

09:10
09/19/18
09/19
09:10
09/19/18
09:10
Hot Stocks
Tecogen adds new Florida service center »

Tecogen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$64.18

0.47 (0.74%)

09:10
09/19/18
09/19
09:10
09/19/18
09:10
Earnings
Copart reports Q4 EPS 412c, consensus 48c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CBRL

Cracker Barrel

$143.77

-6.93 (-4.60%)

09:10
09/19/18
09/19
09:10
09/19/18
09:10
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ADRO

Aduro Biotech

$6.70

0.5 (8.06%)

09:08
09/19/18
09/19
09:08
09/19/18
09:08
Hot Stocks
Aduro Biotech CMO Natalie Sacks to resign »

Aduro Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

LLNW

Limelight Networks

$5.10

0.08 (1.59%)

09:08
09/19/18
09/19
09:08
09/19/18
09:08
Conference/Events
Limelight Networks to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.